Method for preparing bicyclic enol ether
By directly preparing bicyclic enol ethers by reacting a metal catalyst with a cyclic diketone in the presence of a hydrogen source, the multi-step and high toxicity problems in the prior art are solved. A highly efficient and sustainable preparation of bicyclic enol ethers is achieved.
Patent Information
- Application Number
- CN202080006721.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-04-15
- Filing Date
- 2020-04-09
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2040-04-09
AI Technical Summary
In the prior art, the method of preparing bicyclic enol ether derivatives is mostly a multi-step process, including double reduction and dehydrogenation, and it is difficult to directly form enol ethers from the diketone starting material, and there is a problem of using highly toxic reagents.
In the presence of a hydrogen source, the transfer hydrogenation, reduction and cyclization-dehydration reaction is carried out through the reaction of a metal catalyst with a cyclic diketone to directly prepare bicyclic enol ethers, avoiding the formation and separation steps of diols, and using cyclable catalytic system, eliminating toxic agents such as borohydride.
The preparation of bicyclic enol ethers with high yield and good selectivity is achieved, and the conversion rate and sustainability are improved, and the formation of undesirable perhydrogenated glycols is avoided.
Smart Images

Figure CN113166167B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of organic synthesis, and more particularly to a method for preparing a compound of formula (I) by metal complex catalysis. Background Art
[0002] The bicyclic enol ether derivatives of formula (I) are typical intermediates for the preparation of more valuable compounds such as saturated or unsaturated cyclic ketones. For example, 16-oxabicyclo[10.3.1]hexadec-12-ene or 14-methyl-16-oxabicyclo[10.3.1]hexadec-12-ene are highly popular perfume ingredients such as exaltenone or (Trademark of Firmenich SA). For decades, the intermediate has been obtained as a result of the double reduction of macrocyclic diones such as 1,5-cyclopentadecanedione or 3-methylcyclopentadecan-1,5-dione into the corresponding macrocyclic diols such as 1,5-cyclopentadecanedione or 3-methylcyclopentadecanedione-1,5-diol, followed by dehydrogenation and dehydration to form the macrocyclic enol ether. The direct formation of enol ethers from diketone starting materials has never been reported.
[0003] Therefore, there is still a need to develop more direct methods for bicyclic enol ethers with improved yields.
[0004] The present invention obtains the compound of formula (I) starting from the cyclic diketone of formula (II) under transfer hydrogenation conditions which allow the use of secondary alcohols as hydrogen source. Summary of the invention
[0005] The present invention relates to a novel process which allows the preparation of compounds of formula (I) starting from compounds of formula (II) while avoiding the formation and isolation steps of the corresponding diols.
[0006] The object of the present invention is therefore a process for preparing a compound of formula (I),
[0007]
[0008] The compound is in the form of any stereoisomer or a mixture thereof, and wherein R 1 C represents a straight or branched chain 1-5 Alkanediyl or alkenediyl, optionally substituted with phenyl, R 2 C represents a straight or branched chain 1-10 alkanediyl or alkenediyl, optionally substituted with phenyl;
[0009] The method comprises reacting a compound of formula (II) with a metal catalyst in the presence of a hydrogen source:
[0010]
[0011] The compound is in the form of any stereoisomer or a mixture thereof, and wherein R 1 and R 2 has the same meaning as defined in formula (I);
[0012] Provided that the metal catalyst does not include a ruthenium catalyst. DETAILED DESCRIPTION
[0013] Surprisingly, it has now been found that compounds of formula (I) can be prepared in an advantageous manner by a one-pot reduction and cyclization-dehydration type reaction of compounds of formula (II) under transfer hydrogenation conditions. The conditions of the present invention can avoid the difficulty in handling the corresponding diols and have a high selectivity for single reduction reactions. The method of the present invention results in the formation of bicyclic enol ethers in high yields without affecting the conversion rate. In addition, the method of the present invention uses a catalyst system that can be recycled and avoids the use of toxic reagents such as borohydrides, thereby making the conversion more sustainable.
[0014] Therefore, a first object of the present invention is a process for preparing a compound of formula (I),
[0015]
[0016] The compound is in the form of any stereoisomer or a mixture thereof, and wherein R 1 C represents a straight or branched chain 1-5 Alkanediyl or alkenediyl, optionally substituted with phenyl, R 2 C represents a straight or branched chain 1-10 alkanediyl or alkenediyl, optionally substituted with phenyl;
[0017] The method comprises or consists of the following reactions:
[0018] The reaction of the compound of formula (II) with a metal catalyst in the presence of a hydrogen source:
[0019]
[0020] The compound is in the form of any stereoisomer or a mixture thereof, and wherein R 1 and R 2 has the same meaning as defined in formula (I);
[0021] Provided that the metal catalyst does not include a ruthenium catalyst.
[0022] According to any embodiment of the present invention, the process of the present invention is a one-step process.
[0023] According to any embodiment of the invention, the process of the invention is a complete conversion process.
[0024] By "complete conversion process" is meant the normal meaning in the art, ie the process of the present invention is carried out until the compound of formula (II) is completely converted.
[0025] According to any embodiment of the present invention, no compound of formula (III) is formed,
[0026]
[0027] The compound is in the form of any stereoisomer, and wherein R 1 and R 2 has the same meaning as defined in formula (I).
[0028] In other words, the process of the invention allows obtaining the compound of formula (I) in one step without forming the double reduction product of formula (III). The process of the invention allows obtaining mainly the compound of formula (I) without forming the undesired perhydrogenated diol of formula (III); i.e. the process of the invention is highly selective.
[0029] According to any embodiment of the present invention, and regardless of the specific form, compound (I) and corresponding compound (II) may be in the form of any stereoisomer or a mixture thereof. For the sake of clarity, the term stereoisomer refers to any diastereomer, enantiomer, racemate.
[0030] In fact, compound (I) or (II) may have at least one stereogenic center, which may have different stereochemistry (i.e., when there are two stereogenic centers, compound (I) or (II) may have (R, R) or (R, S) configuration). Each of the stereogenic centers may be of relative or absolute configuration R or S or a mixture thereof, or in other words, the compound of formula (II) or (I) may be in the form of pure enantiomers or diastereomers, or a mixture of stereoisomers.
[0031] According to any one of the above embodiments of the present invention, the compound of formula (II) is C7-C 20 Compound.
[0032] According to any one of the above embodiments of the present invention, compound (I) may be a compound of formula (I'):
[0033]
[0034] The compound is in the form of any stereoisomer, and wherein R 2 has the same meaning as defined in formula (I), R 3 Represents a hydrogen atom or a methyl group.
[0035] According to any one of the above embodiments of the present invention, compound (II) may be a compound of formula (II'):
[0036]
[0037] The compound is in the form of any stereoisomer, and wherein R 2 has the same meaning as defined in formula (I), R 3 Represents a hydrogen atom or a methyl group.
[0038] According to any embodiment of the present invention, R 1 represents a linear or branched C optionally substituted with a phenyl group 1-5 Preferably, R 1 C represents a straight or branched chain 1-4 Preferably, R 1 C represents a straight or branched chain 2-3 Even more preferably, R 1 represents 1,2-propylene or 1,2-ethylene. Even more preferably, R 1 represents 1,2-propanediyl.
[0039] According to any embodiment of the present invention, R 2 represents a linear or branched C optionally substituted with a phenyl group 1-10 Preferably, R 2 C represents a straight or branched chain 1-10 Preferably, R 2 C represents a straight or branched chain 4-9 Preferably, R 2 C represents a straight or branched chain 6-9 Even more preferably, R 2 It represents 1,8-octanediyl.
[0040] According to any embodiment of the present invention, R 3 represents a hydrogen atom or a methyl group. Preferably, R 3 Can represent methyl.
[0041] Non-limiting examples of suitable compounds of formula (I) may include 12-oxabicyclo[6.3.1]dodec-8-ene, 10-methyl-12-oxabicyclo[6.3.1]dodec-8-ene, 13-oxabicyclo[7.3.1]tridec-9-ene, 11-methyl-13-oxabicyclo[7.3.1]tridec-9-ene, 14-oxabicyclo[8.3.1]tetradec-10-ene, 12-methyl-14-oxabicyclo[8.3.1]tetradec-10-ene, -10-ene, 15-oxabicyclo[9.3.1]pentadeca-11-ene, 13-methyl-15-oxabicyclo[9.3.1]pentadeca-11-ene, 16-oxabicyclo[10.3.1]hexadec-12-ene, 14-methyl-16-oxabicyclo[10.3.1]hexadec-12-ene, 17-oxabicyclo[11.3.1]heptadec-13-ene or 15-methyl-17-oxabicyclo[11.3.1]heptadec-13-ene. Preferably, the compound of formula (I) may be 16-oxabicyclo[10.3.1]hexadec-12-ene, 14-methyl-16-oxabicyclo[10.3.1]hexadec-12-ene, 17-oxabicyclo[11.3.1]hexadec-13-ene or 15-methyl-17-oxabicyclo[11.3.1]hexadec-13-ene. Preferably, the compound of formula (I) may be 16-oxabicyclo[10.3.1]hexadec-12-ene or 14-methyl-16-oxabicyclo[10.3.1]hexadec-12-ene. Even more preferably, the compound of formula (I) may be 14-methyl-16-oxabicyclo[10.3.1]hexadec-12-ene.
[0042] Non-limiting examples of suitable compounds of formula (II) may include cycloundecane-1,5-dione, 3-methylcycloundecane-1,5-dione, cyclododecane-1,5-dione, 3-methylcyclododecane-1,5-dione, cyclotridecane-1,5-dione, 3-methylcyclotridecane-1,5-dione, cyclotetradecane-1,5-dione, 3-methylcyclotetradecane-1,5-dione, cyclopentadecane-1,5-dione, 3-methylcyclopentadecane-1,5-dione, cyclohexadecane-1,5-dione or 3-methylcyclohexadecane-1,5-dione. Preferably, the compound of formula (II) may be cyclopentadecane-1,5-dione, 3-methylcyclopentadecane-1,5-dione, cyclohexadecane-1,5-dione or 3-methylcyclohexadecane-1,5-dione. Preferably, the compound of formula (II) may be cyclopentadecan-1,5-dione or 3-methylcyclopentadecan-1,5-dione. Even more preferably, the compound of formula (II) may be 3-methylcyclopentadecan-1,5-dione.
[0043] Compounds of formula (II) are commercially available compounds or can be prepared by several methods, for example the methods reported in Helvetica Chimica Acta 1967, 50, 705 or in WO2016104474 or WO2016184948.
[0044] According to any embodiment of the present invention, the catalyst is a metal catalyst. Preferably, the metal catalyst may have the following formula:
[0045] [M(O) m (X) n ] (IV)
[0046] wherein M is a metal selected from transition metals or post-transition metals, m is 0, 1 or 2, X represents an anionic ligand; and wherein n is an integer from 1 to 6.
[0047] According to any of the above embodiments of the present invention, M can be a metal selected from the group consisting of: metals of columns IIIA (e.g., Al), IVA, IIIB, IVB (e.g., Ti or Zr), VB (e.g., V), VIB, and VIIB of the periodic table. Preferably, M can be selected from aluminum, titanium, zirconium, and vanadium.
[0048] According to any of the above embodiments of the present invention, n may be an integer from 1 to 4. Preferably, n may be an integer from 2 to 4. Even more preferably, n may be 3 or 4.
[0049] According to any of the above embodiments of the present invention, X represents an anionic ligand. A non-limiting list of anionic ligands includes hydrogen or halogen atoms, hydroxyl, oxy or β-diketone groups, or alkoxy or carboxyl groups.
[0050] By the term "β-diketonato", it is meant the normal meaning in the art. a (COCHCO) - R a A group in which R a Independently of each other, C1 to C 18 alkyl, and the negative charge is delocalized.
[0051] According to any of the above embodiments of the present invention, in formula (III), each X simultaneously or independently represents a hydrogen or fluorine, chlorine, bromine or iodine atom, a hydroxyl group or an acetylacetonate group, C1 to C 18 Alkoxy such as methoxy, ethoxy or isopropoxy, sec-butoxy, or C1 to C 18Carboxyl groups such as HCOO, CH3COO, CH3CH2COO or phenylCOO groups. Preferably, each X simultaneously or independently represents a hydroxyl, methoxy, ethoxy, propoxy, butoxy, isopropoxy or acetylacetonate group.
[0052] Non-limiting examples of suitable metal catalysts of formula (III) may include [Al(OR)3], [Al(OAc)3], [Al(acac)3], [Ti(OR)4], [Ti(O)(acac)2], [Zr(OR)4], [Zr(acac)4], [V(O)(acac)2], [V(acac)3], [V(O)(OR)3]; R is C 1-6 An alkyl group, preferably R is C 1-4 of alkyl.
[0053] The metal catalyst can be added to the reaction medium of the inventive method at a wide range of concentrations. As non-limiting examples, those metal concentration values of 1000ppm to 100000ppm relative to the total amount of substrate can be cited. Preferably, the metal concentration can be 5000ppm to 15000ppm. Needless to say, the method can also use more catalysts. However, as known to those skilled in the art, the optimum concentration of the metal will depend on the latter's properties, on the properties of the substrate, on the temperature and the time required for the reaction.
[0054] According to any of the above embodiments of the present invention, the hydrogen source is a hydrocarbon containing at least one secondary alcohol functional group and having a boiling point equal to or greater than 80°C, preferably equal to or greater than 110°C, and even more preferably equal to or greater than 120°C. The hydrogen source borrows hydrogen while producing ketones. The borrowed hydrogen source can be a secondary alcohol. In particular, the borrowed hydrogen source can have the following formula:
[0055]
[0056] Where R 4 and R 5 independently represent C optionally substituted with hydroxyl or aryl 1-10 Straight chain alkyl, optionally substituted with hydroxy or aryl C 2-10 Straight chain alkenyl, optionally substituted with hydroxy or aryl C 3-10 branched or cyclic alkyl or alkenyl, or optionally substituted with 1 to 5 C 1-3 alkyl or alkoxy, hydroxy or phenyl with a halogen atom; or R 4 and R 5 When combined together, it represents a C optionally substituted with a hydroxyl or aryl group. 2-10 The hydrogen source of formula (V) is C 4-10 Compound.
[0057] The term "aryl" refers to the normal meaning in the art. That is, an optionally substituted aromatic hydrocarbon group, such as phenyl or naphthyl. Non-limiting examples of optional substituents of aryl may include C 1-3 an alkyl or alkoxy group, a hydroxyl group or a halogen atom.
[0058] According to any of the above embodiments, R 4 may represent a C optionally substituted with a hydroxyl or aryl group 1-10 Straight chain alkyl, or C optionally substituted with hydroxyl or aryl 3-10 branched or cyclic alkyl, or optionally substituted with 1 to 5 C 1-3 Preferably, R 4 may represent a C optionally substituted with a hydroxyl group 1-10 A straight chain alkyl or optionally substituted hydroxyl C 3-10 Preferably, R 4 may represent a C optionally substituted with a hydroxyl group 3-8 More preferably, R 4 May represent methyl, ethyl, propyl, isopropyl, butyl, octyl, optionally substituted with hydroxy.
[0059] According to any of the above embodiments, R 5 may represent a C optionally substituted with a hydroxyl or aryl group 1-10 A straight chain alkyl or C optionally substituted with a hydroxyl or aryl group 3-10 Preferably, R 5 May represent methyl, ethyl or propyl.
[0060] According to any of the above embodiments, when R 4 and R 5 When combined together, it can represent a C optionally substituted with a hydroxyl group 4-7 Preferably, when R 4 and R 5 When combined together, it can represent C 4-7 Even more preferably, when R 4 and R 5 When combined together, it can represent C 4-5 Straight chain alkanediyl.
[0061] Non-limiting examples of suitable hydrogen sources may include 1-phenylethan-1-ol, 2-methyl-2,4-pentanediol, cyclohexanol, 4-methylpentan-2-ol, cyclopentanol or octan-2-ol. Preferably, the hydrogen source may be cyclopentanol or 4-methylpentan-2-ol.
[0062] The hydrogen source can be added to the reaction medium of the inventive method in a wide range of concentrations. As non-limiting examples, values ranging from 1 equivalent to 50 equivalents, or even from 1 equivalent to 5 equivalents, relative to the amount of the compound of formula (II) can be cited as hydrogen source concentration values. It goes without saying that, as known to those skilled in the art, the optimal concentration of the hydrogen source will depend on the nature of the latter, on the nature of the substrate, on the temperature and the catalyst used in the method, and on the time required for the reaction.
[0063] According to any embodiment of the present invention, the method of the present invention can be carried out in the presence of a cocatalyst. Non-limiting examples of suitable cocatalysts include tertiary amines, such as pyridine, bipyridine, trimethylamine, lutidine, N,N-diisopropylethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene or tertiary phosphine, or optionally substituted phenol, or optionally substituted bisphenol. Preferably, the cocatalyst can be a tertiary amine or pyridine or a substituted bisphenol. Even more preferably, the cocatalyst can be a picoline or a dihydroxybiphenyl component, such as 2,2'-dihydroxydiphenylmethane, 2,2'-dihydroxybiphenyl.
[0064] The promoter can be added to the reaction medium of the process of the invention in a wide range of concentrations. As non-limiting examples, values of 0.1 to 2 equivalents relative to the catalyst can be cited as promoter concentrations. It goes without saying that, as known to those skilled in the art, the optimum concentration of the promoter will depend on the nature of the latter, on the nature of the substrate, on the temperature and the catalyst used in the process, and on the time required for the reaction.
[0065] The process of the present invention is carried out under batch or continuous conditions.
[0066] The reaction can be carried out in the absence of a solvent.
[0067] The temperature of the method of the present invention can be in the range of 120° C. to 300° C., more preferably in the range of 150° C. to 250° C. Of course, those skilled in the art can also select the preferred temperature based on the hydrogen source and the melting and boiling points of the starting and final products and the time required for the reaction or conversion.
[0068] The method of the present invention can be carried out under atmospheric pressure or slight vacuum. The method of the present invention can be carried out under an inert atmosphere such as nitrogen or argon.
[0069] According to any one of the above embodiments of the present invention, the more volatile compounds produced in the process of the present invention are continuously removed in the process of the present invention. The more volatile compounds formed in the process of the present invention, such as water and ketones, can be removed by distillation in the process of the present invention.
[0070] Example
[0071] The present invention will now be described in more detail by the following examples, in which abbreviations have their usual meanings in the art, temperatures are expressed in degrees Celsius (° C.); NMR spectral data are for 1 H and 13 C was recorded in CDCl3 using a 360 MHz or 400 MHz machine (if not stated otherwise), chemical shifts δ are expressed in ppm relative to TMS as a standard, coupling constants J are expressed in Hz.
[0072] Example 1
[0073] The compound of formula (I) is prepared from the compound of formula (II)
[0074] In a 1L glass reactor equipped with a mechanical stirrer, a packed column, and a reflux condenser, 250 g of 3-methyl-1,5-cyclopentadecanedione (0.99 mole), 50 g of a hydrogen source (see Table 1) and V(acac)3 (17.2 g, 0.049 mol) were added at atmospheric pressure. The mixture was stirred and heated to reflux, and then the remaining hydrogen source (450 g) was metered in over 22 hours, while the light fractions (water and the resulting ketone) formed during the reaction were distilled into a flask. The resulting mixture was cooled to 100°C, and the remaining solvent was concentrated under vacuum. The residual oil (230 g) was flashed (170°C, 1 mbar), and the distillate was analyzed by GC (see Table 1).
[0075] Table 1 : Preparation of compound of formula (I) by compound of formula (II)
[0076]
[0077] 1) Add 10% of the total amount in advance, and then add the remainder over 16 hours.
[0078] 2) Mainly full conversion rate and high selectivity.
[0079] Example 2
[0080] The compound of formula (I) is prepared from the compound of formula (II)
[0081] In a 1L glass reactor equipped with a mechanical stirrer, a packed column, and a reflux condenser, 250 g of 3-methyl-1,5-cyclopentadecanedione (0.99 mol), 50 g of cyclohexanol, Zr(OPr)4 (4.63 g, 0.0098 mol, 70% in PrOH) and 2,2'-dihydroxydiphenylmethane (1.59 g, 0.0098 mol) were added at atmospheric pressure. The mixture was stirred and heated to reflux, and then the remaining hydrogen source (450 g) was metered in over 22 hours, while the light fractions (water, cyclohexanol, cyclohexanone) formed during the reaction were distilled into a flask. The resulting mixture was cooled to 100°C, and the remaining solvent was concentrated under vacuum. The residual oil (242 g) was flashed (170°C, 1 mbar), and the distillate was analyzed by GC (Compound I, purity 92.7%, yield 91.2%). No 3-methyl-1,5-cyclopentadecanediol was formed, and 3-methyl-1,5-cyclopentadecanedione was completely converted.
[0082] Example 3
[0083] The compound of formula (I) is prepared from the compound of formula (II)
[0084] In a 1L glass reactor equipped with a mechanical stirrer, a packed column, and a reflux condenser, 250 g of 3-methyl-1,5-cyclopentadecanedione (0.99 mol), 50 g of 2-octanol, Zr(OPr)4 (9.26 g, 0.0196 mol, 70% in PrOH) and 2,2'-dihydroxybiphenyl (3.7 g, 0.0196 mol) were added at 200 mbar. The mixture was stirred and heated to reflux, and then the remaining hydrogen source (250 g) was metered in over 16 hours, while the light fractions (water, 2-octanol, 2-octanone) formed during the reaction were distilled into a flask. The resulting mixture was cooled to 100°C, and the remaining solvent was concentrated under vacuum. The residual oil (230 g) was flashed (180°C, 1 mbar), and the distillate was analyzed by GC (compound I, purity 89.2%, yield 94.1%). No 3-methyl-1,5-cyclopentadecanediol was formed, and 3-methyl-1,5-cyclopentadecanedione was completely converted.
[0085] Example 4
[0086] The compound of formula (I) is prepared from the compound of formula (II)
[0087] In a 1 L glass reactor equipped with a mechanical stirrer, a packed column, a reflux condenser, 250 g of 3-methyl-1,5-cyclopentadecanedione (0.99 mol), 50 g of a hydrogen source (see Table 2), Ti(OiPr)4 (5.6 g, 0.02 mol) and 2,2'-dihydroxybiphenyl (3.7 g, 0.02 mol) were added at the pressure indicated in Table 2. The mixture was stirred and heated to reflux, and then the remaining hydrogen source (450 g) was metered in over 22 hours, while the light fractions formed during the reaction (water and the resulting ketone) were distilled into the flask. The resulting mixture was cooled to 100 ° C, and the remaining solvent was concentrated under vacuum. The residual oil (≈230 g) was flashed (170 ° C, 1 mbar), and the distillate was analyzed by GC (see Table 2).
[0088] Table 2 : Preparation of compound of formula (I) by compound of formula (II)
[0089]
[0090] 1) Add 10% of the total amount in advance, and then add the remainder over 16 hours.
[0091] 2) Mainly full conversion rate and high selectivity.
[0092] Example 5
[0093] The compound of formula (I) is prepared from the compound of formula (II)
[0094] In a 1L glass reactor equipped with a mechanical stirrer, a packed column, and a reflux condenser, 250 g of 3-methyl-1,5-cyclopentadecanedione (0.99 mol), 50 g of cyclopentanol, Al(OBu)3 (12.3 g, 0.05 mol) and 2,2'-dihydroxydiphenylmethane (8 g, 0.05 mol) were added at atmospheric pressure. The mixture was stirred and heated to reflux, and then the remaining hydrogen source (450 g) was metered in over 22 hours, while the light fractions (water, cyclopentanol, cyclopentanone) formed during the reaction were distilled into a flask. The resulting mixture was cooled to 100°C, and the remaining solvent was concentrated under vacuum. The residual oil (247 g) was flashed (170°C, 1 mbar), and the distillate was analyzed by GC (Compound I, purity 85%, yield 85%). No 3-methyl-1,5-cyclopentadecanediol was formed, and 3-methyl-1,5-cyclopentadecanedione was completely converted.
Claims
1. A method for preparing a compound of formula (I), The compound is in the form of any stereoisomer or a mixture thereof, and wherein R 1 C represents a straight or branched chain 1-5 Alkanediyl, R 2 C represents a straight or branched chain 1-10 Alkanediyl; The method comprises reacting a compound of formula (II) with a metal catalyst in the presence of a hydrogen source and in the presence of a co-catalyst: The compound is in the form of any stereoisomer or a mixture thereof, and wherein R 1 and R 2 has the same meaning as defined in formula (I); Provided that the metal catalyst does not include a ruthenium catalyst, and the metal catalyst is selected from the group consisting of: [Al(OR)3], [Al(OAc)3], [Al(acac)3], [Ti(OR)4], [Ti(O)(acac)2], [Zr(OR)4], [Zr(acac)4], [V(O)(acac)2], [V(acac)3] and [V(O)(OR)3]; R is C 1-6 The alkyl group wherein the method is a one-pot reduction and cyclization-dehydration type reaction of the compound of formula (II) under transfer hydrogenation conditions, and the cocatalyst is a tertiary amine, a tertiary phosphine, an optionally substituted phenol, or an optionally substituted bisphenol, Wherein the hydrogen source has the formula: Where R 4 and R 5 independently represent C optionally substituted with hydroxyl 1-10 Straight chain alkyl, optionally substituted with hydroxyl C 3-10 branched or cyclic alkyl, or phenyl; or R 4 and R 5 When combined together, it represents C 4-5 Straight chain alkanediyl.
2. The method according to claim 1, characterized in that R 1 C represents a straight or branched chain 1-4 Alkanediyl.
3. The method according to claim 1 or 2, characterized in that R 1 C represents a straight or branched chain 2-3 Alkanediyl.
4. The method according to claim 1, characterized in that R 1 represents 1,2-propylene or 1,2-ethylene.
5. The method according to claim 1, characterized in thatR 2 C represents a straight or branched chain 4-9 Alkanediyl.
6. The method according to claim 1, characterized in that R 2 C represents a straight or branched chain 6-9 Alkanediyl.
7. The method according to claim 1, characterized in that R 2 It represents 1,8-octanediyl.
8. The method according to claim 1, characterized in that The compound of formula (I) is selected from the group consisting of 12-oxabicyclo[6.3.1]dodec-8-ene, 10-methyl-12-oxabicyclo[6.3.1]dodec-8-ene, 13-oxabicyclo[7.3.1]tridec-9-ene, 11-methyl-13-oxabicyclo[7.3.1]tridec-9-ene, 14-oxabicyclo[8.3.1]tetradec-10-ene, 12-methyl-14-oxabicyclo[8.3.1]tetradec-10-ene, 10-ene, 15-oxabicyclo[9.3.1]pentadeca-11-ene, 13-methyl-15-oxabicyclo[9.3.1]pentadeca-11-ene, 16-oxabicyclo[10.3.1]hexadec-12-ene, 14-methyl-16-oxabicyclo[10.3.1]hexadec-12-ene, 17-oxabicyclo[11.3.1]heptadec-13-ene and 15-methyl-17-oxabicyclo[11.3.1]heptadec-13-ene.
9. The method according to claim 1, characterized in that The compound of formula (II) is selected from the group consisting of cycloundecane-1,5-dione, 3-methylcycloundecane-1,5-dione, cyclododecane-1,5-dione, 3-methylcyclododecane-1,5-dione, cyclotridecane-1,5-dione, 3-methylcyclotridecane-1,5-dione, cyclotetradecane-1,5-dione, 3-methylcyclotetradecane-1,5-dione, cyclopentadecane-1,5-dione, 3-methylcyclopentadecane-1,5-dione, cyclohexadecane-1,5-dione and 3-methylcyclohexadecane-1,5-dione.
10. The method according to claim 1, characterized in that The cocatalyst is selected from the group consisting of pyridine, bispyridine, trimethylamine, lutidine, N,N-diisopropylethylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene, a tertiary phosphine, an optionally substituted phenol, and an optionally substituted bisphenol.
11. The method according to claim 1, characterized in that The co-catalyst is selected from the group consisting of picoline, 2,2'-dihydroxydiphenylmethane, and 2,2'-dihydroxybiphenyl.
12. The method according to claim 1, characterized in that The hydrogen source contains at least one secondary alcohol functional group and has a boiling point equal to or greater than 80°C.
13. The method according to claim 1, characterized in that The hydrogen source is 1-phenylethan-1-ol, 2-methyl-2,4-pentanediol, cyclohexanol, 4-methylpentan-2-ol, cyclopentanol or octan-2-ol.
